Insider · CIK 0001569926

Nolan Sean P.

Reports to the SEC for 6 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001569926

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-13	VTRVentas, Inc.A Award	Director	AAward	+2,047 sh	$90.35	+$185K	26,181
2026-01-26	TSHATaysha Gene Therapies, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.3K sh	$4.61	−$190K	2,908,257
2026-01-23	TSHATaysha Gene Therapies, Inc.S Sale	Director, Chief Executive Officer	SSale	−137K sh	$4.75	−$650K	2,949,569
2026-01-12	TSHATaysha Gene Therapies, Inc.A Award	Director, Chief Executive Officer	AAward	+1.01M sh	—	—	3,086,358
2026-01-12	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+648K sh	—	—	648,000
2025-05-13	VTRVentas, Inc.A Award	Director	AAward	+2,882 sh	$64.18	+$185K	24,134
2025-01-02	TSHATaysha Gene Therapies, Inc.A Award	Director, Chief Executive Officer	AAward	+893K sh	—	—	2,078,358
2025-01-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+893K sh	—	—	892,500
2024-05-14	VTRVentas, Inc.A Award	Director	AAward	+3,648 sh	$47.96	+$175K	21,252
2024-01-02	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.18M sh	—	—	1,184,688
2024-01-02	TSHATaysha Gene Therapies, Inc.A Award	Director, Chief Executive Officer	AAward	+1.18M sh	—	—	1,185,858
2023-12-14	TSHATaysha Gene Therapies, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+467K sh	—	—	466,550
2023-08-16	TSHATaysha Gene Therapies, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+444K sh	$0.90	+$400K	1,535,545
2023-05-16	VTRVentas, Inc.A Award	Director	AAward	+3,835 sh	$45.63	+$175K	17,604
2022-12-30	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.11M sh	—	—	1,106,131
2022-06-17	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+15.5K sh	—	—	15,500
2022-04-27	VTRVentas, Inc.A Award	Director	AAward	+3,056 sh	$57.25	+$175K	13,769
2021-06-17	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+15.5K sh	—	—	15,500
2021-05-25	VTRVentas, Inc.A Award	Director	AAward	+3,158 sh	—	—	10,713
2021-05-20	TSHATaysha Gene Therapies, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,170 sh	$22.35	+$26.1K	1,170
2020-09-28	TSHATaysha Gene Therapies, Inc. · Series B Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−1,470 sh	—	—	0
2020-09-28	TSHATaysha Gene Therapies, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+1.09M sh	—	—	1,089,500
2020-09-28	TSHATaysha Gene Therapies, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+1,601 sh	—	—	1,091,101
2020-09-28	TSHATaysha Gene Therapies, Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−1M sh	—	—	0
2020-09-23	TSHATaysha Gene Therapies, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+31K sh	—	—	31,000
2020-07-21	VTRVentas, Inc.P Purchase	Director	PPurchase	+37 sh	$34.21	+$1,265.929	87
2020-07-21	VTRVentas, Inc.P Purchase	Director	PPurchase	+27 sh	$34.21	+$923.781	63
2020-05-18	VTRVentas, Inc.A Award	Director	AAward	+5,424 sh	—	—	7,555
2020-05-05	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-04-20	VTRVentas, Inc.P Purchase	Director	PPurchase	+50 sh	$27.70	+$1,384.83	50
2020-04-20	VTRVentas, Inc.P Purchase	Director	PPurchase	+36 sh	$27.70	+$997.07	36
2019-10-10	NGNENeurogene Inc. · Stock Option (right to buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-07-26	VTRVentas, Inc.A Award	Director	AAward	+2,131 sh	$67.03	+$143K	2,131
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−96K sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−44K sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−110K sh	—	—	0
2018-05-15	AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−728K sh	—	—	0
2018-05-15	AveXis, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−11K sh	—	—	0
2018-05-07	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-03-13	AveXis, Inc.A Award	Director, President & CEO	AAward	+11K sh	—	—	11,000
2018-03-13	AveXis, Inc.Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+44K sh	—	—	44,000
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−700 sh	$127.65	−$89.4K	8,900
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−400 sh	$126.65	−$50.7K	9,600
2018-03-07	AveXis, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$15.94	+$159K	10,000
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−2,400 sh	$128.65	−$309K	6,500
2018-03-07	AveXis, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	728,300
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−1,100 sh	$131.86	−$145K	0
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−600 sh	$130.78	−$78.5K	1,100
2018-03-07	AveXis, Inc.S Sale	Director, President & CEO	SSale	−4,800 sh	$129.66	−$622K	1,700
2017-05-10	AveXis, Inc.Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+96K sh	—	—	96,000

Recent filings

Accepted (ET)
May 154
Nolan Sean P.0001569926-26-000012
SEC(opens sec.gov)
Feb 175
Nolan Sean P.0001569926-26-000010
SEC(opens sec.gov)
Jan 274
Nolan Sean P.0001569926-26-000008
SEC(opens sec.gov)
Jan 144
Nolan Sean P.0001569926-26-000002
SEC(opens sec.gov)
May 154
Nolan Sean P.0000740260-25-000175
SEC(opens sec.gov)
Jan 34
Nolan Sean P.0001415889-25-000599
SEC(opens sec.gov)
May 164
Nolan Sean P.0000740260-24-000162
SEC(opens sec.gov)
Jan 44
Nolan Sean P.0001209191-24-000807
SEC(opens sec.gov)
Dec 184
Nolan Sean P.0001209191-23-058971
SEC(opens sec.gov)
Aug 164
Nolan Sean P.0001209191-23-046150
SEC(opens sec.gov)
May 184
Nolan Sean P.0000740260-23-000123
SEC(opens sec.gov)
Jan 44
Nolan Sean P.0001209191-23-001020
SEC(opens sec.gov)
Jun 224
Nolan Sean P.0001209191-22-038689
SEC(opens sec.gov)

Companies

Address

C/O VENTAS, INC. 300 NORTH LASALLE ST., SUITE 1600

CHICAGO, IL, 60654